---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-329618"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2026-08-03T12:32:42+00:00"
generated_at: "2026-08-03T12:35:09.826883+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "medium"
source: SEC EDGAR
---

# Indivior and Supernus announce merger of equals to create diversified CNS leader

## Summary
- Merger of equals under Agreement and Plan of Merger dated August 1, 2026.
- Joint investor presentation and conference call held on August 3, 2026.
- Transaction includes a special dividend and additional indebtedness; terms not disclosed.
- Closing subject to stockholder and regulatory approvals; S-4 registration statement to be filed.
- Combined company expected to have significant scale in CNS biopharmaceuticals.

## SEC filing metadata
- accession: 0001193125-26-329618
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2026-08-03T12:32:42+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000119312526329618/0001193125-26-329618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000119312526329618/d166865d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-329618
- JSON: https://secwatch.observer/filing/0001193125-26-329618.json
- Plain text: https://secwatch.observer/filing/0001193125-26-329618.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.